TOMDF — Todos Medical Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $36.78m
- $12.23m
Annual income statement for Todos Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 5.21 | 12.2 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 1.39 | 4.38 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.34 | 1.38 | 4.94 | 19.5 | 23.5 |
Operating Profit | -1.34 | -1.38 | -4.94 | -14.3 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.68 | -0.458 | -11.8 | -29.8 | -43.3 |
Net Income After Taxes | -2.68 | -0.458 | -11.8 | -29.8 | -43.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.68 | -0.458 | -11.8 | -29.8 | -43.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.68 | -0.458 | -11.8 | -29.8 | -43.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.039 | -0.006 | -0.113 | -0.083 | -0.061 |